A carregar...

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020

BACKGROUND: The majority of current pharmacological treatments for Parkinson’s disease (PD) were approved for clinical use in the second half of the last century and they only provide symptomatic relief. Derivatives of these therapies continue to be explored in clinical trials, together with potenti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Parkinsons Dis
Main Authors: McFarthing, Kevin, Buff, Sue, Rafaloff, Gary, Dominey, Thea, Wyse, Richard K., Stott, Simon R.W.
Formato: Artigo
Idioma:Inglês
Publicado em: IOS Press 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7458531/
https://ncbi.nlm.nih.gov/pubmed/32741777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-202128
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!